Abstract
Online tools, such as web-based applications, aid medical doctors in recommending treatments and conducting thorough patient profile investigations. Prior studies have created web-based survival analysis tools for cancer survival. However, these often offer basic features and simplistic models, providing shallow data insights. Our research involves an in-depth risk profile analysis using survival clustering on real-world data. We’ve developed a user-friendly Shiny application to simplify the use of our findings. By utilizing survival clustering, we uncover distinct subgroups and unique risk profiles among breast cancer patients. Our online app empowers researchers and clinicians to explore and gain insights into breast cancer risk profiles, enhancing personalized medicine and clinical decision-making.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used (or will use) ONLY openly available human data that were originally located at: https://www.cbioportal.org/study/clinicalData?id=brca_metabric
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
model revised, Figures are revised.
Data Availability
All data produced are available online at
https://www.cbioportal.org/study/clinicalData?id=brca_metabric
